At the OHSU Knight Cancer Institute in Portland, Oregon, Terry collaborates with industry and academic partners to bring cutting-edge technologies to bear on research programs in cancer precision medicine and early detection, with the goal of translating innovative research into benefits for patients. The Knight Cancer Institute, designated a Comprehensive Cancer Center by the National Cancer Institute, is known as one of the pioneers in personalized cancer medicine and is driven by its mission to end cancer as we know it.
Terry earned his Doctorate in Biochemistry at the University of British Columbia in Vancouver, Canada, and served as a Postdoctoral Fellow at the Scripps Research Institute in La Jolla, California. His research centered on the use of structural biology and computational biology to understand protein function in contexts spanning from human disease to basic biology. Terry has also worked in the private sector in biotechnology, intellectual property and investment analysis roles.
Will AI Make Us Healthier?
Medical researchers are using artificial intelligence to identify at-risk patients, predict issues before symptoms arise, and potentially save lives. Collaboration between public and private sector, for example, is leading to groundbreaking new developments to images and detect patterns at massive scale. The following transcript has been lightly edited and condensed for ease of reading. […]
Conferences
NYC 19
The world is in sad shape, which means, among other challenging realities, that all of us need to ensure our work contributes to larger solutions. Tech changes everything, which we love, but it can’t just be a way to make more money.
